Brian advises a wide range of life sciences companies and health care providers on federal legal, regulatory and legislative policy matters impacting the commercialization of novel technologies. Over the past two decades, his insight and knowledge of the life sciences sector has guided numerous biotechnology, medical device companies, health care providers through the regulatory pathways to successfully launch new technologies.
As a Co-Chair of the Life Sciences Coverage & Payment Group, Brian has deep experience with biopharma and medical technology companies on Medicare coverage and payment, and food and drug approval issues for innovative technologies. He regularly advocates on behalf of technology developers and medical trade associations before the U.S. Congress, U.S. Department of Health and Human Services, and federal agencies. His insights help advise investors appreciate regulatory risk and opportunity for new technologies.More »